Stansberry Asset Management, LLC Sangamo Therapeutics, Inc Transaction History

Stansberry Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $3.16 Million - $5.52 Million	-332,580 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $1.07 Million - $1.56 Million	81,999 Added 32.72%	332,580 $5.64 Million
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $3.48 Million - $4.96 Million	250,581 New	250,581 $3.56 Million

141

60.4M

1.46M

1.84M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $133M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stansberry Asset Management, LLC with notifications on news.